Verastem, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Verastem, Inc. on May 14, 2019, in Needham, Massachusetts. The filing details the outcomes of three specific proposals submitted to security holders for a vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results rather than financial performance.
Material Changes and Voting Results
The following proposals were acted upon by stockholders:
- Proposal 1: Election of Class I Directors
- Michael Kaufmann, M.D.: Elected with 19,384,422 votes for, 4,498,255 votes withheld, and 38,103,983 broker non-votes.
- Eric Rowinsky, M.D.: Elected with 13,708,551 votes for, 10,174,126 votes withheld, and 38,103,983 broker non-votes.
- Proposal 2: Ratification of Independent Auditor
- Stockholders ratified the selection of Ernst & Young LLP.
- Votes: 56,127,092 for, 2,617,081 against, 3,242,487 abstained.
- Proposal 3: Advisory Vote on Executive Compensation
- Stockholders approved the compensation of Named Executive Officers on a non-binding basis.
- Votes: 18,153,297 for, 2,308,728 against, 3,420,652 abstained, with 38,103,983 broker non-votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the tenure of the newly elected Class I directors (Michael Kaufmann and Eric Rowinsky) until the 2022 Annual Meeting.
- Note the significant number of broker non-votes (38,103,983) on the director election and executive compensation proposals.
- Confirm the continued engagement of Ernst & Young LLP as the independent registered public accounting firm.